FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 12.92

Change

-0.25 (-1.90)%

Market Cap

CAD 0.05B

Volume

562.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-1.64 (-4.84%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.39 (-1.38%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.19 (-0.78%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-1.70 (-4.76%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.44 (+0.95%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.75 (-2.65%)

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

-0.71 (-6.12%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.12 (-0.52%)

CAD 2.78B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.45% 88% B+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.45% 88% B+ 76% C+
Trailing 12 Months  
Capital Gain 0.62% 24% F 28% F
Dividend Return 1.70% 43% F 29% F
Total Return 2.32% 19% F 25% F
Trailing 5 Years  
Capital Gain 26.17% 36% F 37% F
Dividend Return 35.92% 85% B 75% C
Total Return 62.09% 41% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain 3.99% 52% F 46% F
Dividend Return 4.64% 53% F 43% F
Total Return 0.65% 71% C- 30% F
Risk Return Profile  
Volatility (Standard Deviation) 4.85% 83% B 92% A
Risk Adjusted Return 95.58% 95% A 91% A-
Market Capitalization 0.05B 43% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.